Tretten

FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
Yahoo/Fly on the Wall
Mon, 12/23/13 - 03:22 pm
Novo Nordisk
Tretten
FDA
congenital Factor XIII A-subunit deficiency